Skip to main content
Kolinpharma logo

Kolinpharma — Investor Relations & Filings

Ticker · KIP ISIN · IT0005322950 LEI · 815600FC8F1A3BED2743 XMIL Manufacturing
Open in API
Filings indexed 222 across all filing types
Latest filing 2022-09-13 Transaction in Own Shar…
Country IT Italy
Listing XMIL KIP

About Kolinpharma

https://www.kolinpharma.com/index-en

Kolinpharma is a nutraceutical company established in 2013, specializing in the research and development of innovative products designed to improve well-being and quality of life. The company's core activities are centered on scientific research and product innovation, creating high-quality nutraceuticals. It operates an in-house R&D department and collaborates with leading universities for in-vitro and clinical studies. As a certified B Corporation, Kolinpharma adheres to high standards of social and environmental performance. The company distributes its proprietary branded products through a qualified network of medical-scientific representatives.

Recent filings

Filing Released Lang Actions
Kolinpharma, buy-back
Transaction in Own Shares Classification · 1% confidence The document is explicitly titled 'COMUNICATO STAMPA PRICE SENSITIVE' (Price Sensitive Press Release) and the subject is 'Comunicazione sullo stato di attuazione del Programma di ri-acquisto azioni proprie' (Communication on the status of the implementation of the own share repurchase program) for the period August 29 – September 2, 2022. This type of communication, detailing the status of a share buyback program, is a specific corporate action update. While it relates to capital structure, the most precise fit among the provided definitions is 'Transaction in Own Shares' (POS), which covers share repurchase reports. The document is short and serves as a notification of the status (no operations conducted) rather than a comprehensive financial report (like 10-K or IR).
2022-09-13 Italian
Kolinpharma, cs buy-back
Transaction in Own Shares Classification · 1% confidence The document is titled 'COMUNICATO STAMPA PRICE SENSITIVE' (Price Sensitive Press Release) and the subject is 'Comunicazione sullo stato di attuazione del Programma di ri-acquisto azioni proprie' (Communication on the status of implementation of the own share repurchase program) for the period August 22-26, 2022. This explicitly details the company's activity regarding buying back its own shares. This directly corresponds to the definition for Transaction in Own Shares (POS). Although it is a press release, the core content is the transaction report itself, not just an announcement that a report is forthcoming (which would suggest RPA or RNS). Since POS is a specific category for share repurchase/issuance, it is preferred over the general RNS.
2022-09-13 Italian
Kolinpharma, aggiornamento buy-back
Transaction in Own Shares Classification · 1% confidence The document is titled 'Comunicazione sullo stato di attuazione del Programma di ri-acquisto azioni proprie' (Communication on the status of implementation of the own share repurchase program) and reports on the period from August 15 to 19, 2022, stating that no repurchase operations were executed. This directly relates to the company buying back or selling its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). Although it is a short communication, the subject matter is specific enough to avoid the general 'RPA' or 'RNS' fallback.
2022-08-31 Italian
Kolinpharma, aggiornamento buy-back
Transaction in Own Shares Classification · 1% confidence The document is titled 'Comunicazione sullo stato di attuazione del Programma di ri-acquisto azioni proprie' (Communication on the status of implementation of the share buy-back program) and reports on transactions (or lack thereof) related to the company buying back its own shares for the period August 8-12, 2022. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase reports. Although it is a short press release, the core subject matter is the buyback activity, making POS a more specific fit than the general RPA or RNS categories.
2022-08-31 Italian
KOLINPHARMA, riepilogo operazioni buy-back relative al mese luglio
Transaction in Own Shares Classification · 1% confidence The document is a formal disclosure titled "SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI DELL'EMITTENTE" (Model Disclosure for Transactions in the Issuer's Securities). Section 2 details transactions, and Section 3 specifically discusses the 'PROGRAMMA DI ACQUISTO E VENDITA DI AZIONI PROPRIE' (Program for the Purchase and Sale of Treasury Shares). This structure, reporting on the company's own share transactions (buybacks or sales), directly corresponds to the definition of 'Transaction in Own Shares'. The reference to 'riepilogo operazioni buy' (summary of buy operations) in the header further confirms this. Therefore, the appropriate code is POS.
2022-08-09 Italian
kolinpharma, aggiornamento buy-back
Transaction in Own Shares Classification · 1% confidence The document is titled "COMUNICATO STAMPA PRICE SENSITIVE" (Price Sensitive Press Release) and the subject is "kolinpharma, aggiornamento buy-back" (kolinpharma, buy-back update). It specifically reports on the status of the share repurchase program for the period August 1-5, 2022, noting that no shares were repurchased. This content directly relates to the company's own shares being transacted in the market. The category 'Transaction in Own Shares' (Code: POS) is the most appropriate fit for reporting on share buyback activities and current holdings of treasury stock. Although it is a price-sensitive announcement, the core subject matter is the transaction itself, making POS more specific than ER or RNS.
2022-08-08 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.